Nobilis Therapeutics leadership will be attending J.P.Morgan’s 36th Annual Healthcare Conference that will take place in San Francisco on January 8-11. If you are interested in setting up a f2f meeting with our team, please send us an email.
News
- Nobilis Therapeutics Receives a Notice of Allowance from USPTO for a Patent Covering Treatments of Rheumatologic Disorders with Noble Gases March 14, 2018
- Nobilis Therapeutics issues a press release after a productive meeting with the House of Representatives Committee on Veterans’ Affairs. February 23, 2018
- On February 21st Nobilis Therapeutics will present its PTSD clinical program to the US Congress February 18, 2018
- Nobilis Therapeutics will present its clinical study of the use of NBTX-001 in patients with Panic Disorder at the ADAA annual meeting January 31, 2018
- Nobilis Therapeutics to attend J.P.Morgan’s 36th Annual Healthcare Conference December 20, 2017
Recent Posts
- Nobilis Therapeutics Receives a Notice of Allowance from USPTO for a Patent Covering Treatments of Rheumatologic Disorders with Noble Gases
- Nobilis Therapeutics issues a press release after a productive meeting with the House of Representatives Committee on Veterans’ Affairs.
- On February 21st Nobilis Therapeutics will present its PTSD clinical program to the US Congress
- Nobilis Therapeutics will present its clinical study of the use of NBTX-001 in patients with Panic Disorder at the ADAA annual meeting
- Nobilis Therapeutics to attend J.P.Morgan’s 36th Annual Healthcare Conference
Recent Comments